ERDRP-0519

CAS No. 1374006-96-8

ERDRP-0519( —— )

Catalog No. M33982 CAS No. 1374006-96-8

ERDRP-0519 is an orally bioavailable small-molecule inhibitor of the Measles virus (MeV) polymerase.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 211 Get Quote
5MG 330 Get Quote
10MG 464 Get Quote
25MG 722 Get Quote
50MG 1030 Get Quote
100MG 1332 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    ERDRP-0519
  • Note
    Research use only, not for human use.
  • Brief Description
    ERDRP-0519 is an orally bioavailable small-molecule inhibitor of the Measles virus (MeV) polymerase.
  • Description
    ERDRP-0519, an orally bioavailable small-molecule Measles virus (MeV) polymerase inhibitor, prevents measles disease in squirrel monkeys (Saimiri sciureus). ERDRP-0519 inhibits morbilliviruses with nanomolar potency..
  • In Vitro
    ERDRP-0519 exhibits potency against a panel of Measles virus (MeV) isolates with EC50s of 0.07- 0.3 μM. ERDRP-0519 exhibits potency against MeV and related pathogens of the?Morbillivirus?genus, such as canine distemper virus (CDV).
  • In Vivo
    A single-dose pharmacokinetic (PK) study is performed in squirrel monkeys by oral (intragastric) delivery of ERDRP-0519 (50?mg/kg) and blood sampling at seven predefined time points after dosing. Serum concentrations peak ~2?h post-administration (Cmax=3.27?μM).
  • Synonyms
    ——
  • Pathway
    Immunology/Inflammation
  • Target
    Antiviral
  • Recptor
    Antiviral
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1374006-96-8
  • Formula Weight
    529.58
  • Molecular Formula
    C23H30F3N5O4S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (188.83 mM; Ultrasonic )
  • SMILES
    Cn1nc(cc1C(=O)Nc1ccc(cc1)S(=O)(=O)N1CCCC[C@H]1CCN1CCOCC1)C(F)(F)F
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Stefanie A Krumm, et al. An orally available, small-molecule polymerase inhibitor shows efficacy against a lethal morbillivirus infection in a large animal model. Sci Transl Med.?2014 Apr 16;6(232):232ra52.?
molnova catalog
related products
  • DPPG sodium

    DPPG sodium (1,2-Dipalmitoyl-sn-glycero-3-PG sodium) is a liposome that is a surfactant and inhibits cowpox virus infection.

  • Antiviral agent 38

    2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1, 1-Dimethylethyl)-6, 7-Dihydro-10 -(3-methoxypropoxy)-2-oxo-, (6R)- has antibacterial and antiviral activity and can be used to study Hepatitis B virus.

  • Pritelivir

    Pritelivir (BAY 57-1293) is a potent helicase-primase inhibitor with active against HSV-1 and HSV-2 (IC50: 20 nM).